- Report
- September 2025
- 21 Pages
Lithuania
From €995EUR$1,218USD£895GBP
- Report
- September 2025
- 55 Pages
Paraguay
From €2150EUR$2,632USD£1,934GBP
- Report
- September 2025
- 84 Pages
Estonia
From €2675EUR$3,274USD£2,407GBP
- Report
- September 2025
- 22 Pages
Estonia
From €995EUR$1,218USD£895GBP
- Report
- September 2025
- 118 Pages
Mexico
From €2675EUR$3,274USD£2,407GBP
- Report
- September 2025
- 105 Pages
Chile
From €2675EUR$3,274USD£2,407GBP
- Report
- September 2025
- 23 Pages
China
From €995EUR$1,218USD£895GBP
- Report
- September 2025
- 27 Pages
Mexico
From €995EUR$1,218USD£895GBP
- Report
- September 2025
- 24 Pages
Chile
From €995EUR$1,218USD£895GBP
- Report
- September 2025
- 23 Pages
Argentina
From €995EUR$1,218USD£895GBP
- Report
- March 2024
- 132 Pages
Global
From €831EUR$950USD£723GBP
The Antacid market is a segment of the Over the Counter (OTC) Drugs industry. Antacids are used to treat symptoms of acid reflux, heartburn, and indigestion. They are available in a variety of forms, including tablets, liquids, and chewable gummies. Antacids are generally safe and effective, and can be purchased without a prescription.
The Antacid market is highly competitive, with a wide range of products available from both large and small companies. Many of the products are marketed as being fast-acting and long-lasting, and some are formulated to provide additional benefits such as relief from gas and bloating.
Some of the companies in the Antacid market include GlaxoSmithKline, Pfizer, Bayer, Johnson & Johnson, Novartis, and Procter & Gamble. Show Less Read more